AI Clinical Software. Decoded.

The intelligence layer for investors assessing regulated AI clinical software startups and scaleups.

Regulatory maturity and clinical evidence — mapped into actionable company signals.

Platform preview

Structured intelligence on AI clinical software startups and scaleups.

We organize regulatory maturity and clinical evidence signals into comparable company profiles for investors assessing regulated AI clinical software.

Explore the Platform

Cobalt Platform

Company View

Signals

Regulatory maturity Medium

Clinical evidence Emerging

Market segment Diagnostic AI

Company stage Scaleup

CE-marked medical software identified

Clinical validation evidence available

Venture-backed company profile

Platform coverage

Current coverage of the AI clinical software market.

250+

Startups and scaleups assessed

Countries covered

AI clinical software segments

10+

Company signal fields tracked

Countries assessed

Switzerland Germany France United Kingdom Netherlands Sweden Denmark Spain Italy Belgium Finland Israel United States

Segments mapped

Diagnostic AI Clinical Decision Support Risk Prediction Triage Imaging AI Remote Monitoring Digital Biomarkers Workflow AI

Company signal fields

Company profile

Name, website, country, stage, operational status.

Market positioning

Primary segment, clinical area, target setting, software category.

Regulatory signal

Regulatory profile, CE/FDA visibility, medical software relevance.

Clinical evidence signal

Evidence level, publication visibility, validation signal, source links.